New data supports the potential role of Artificial Intelligence (AI) in predicting patients’ response to immunotherapies in advance of their treatment.
GE HealthCare’s Artificial Intelligence...
Medidata to announce latest innovations to accelerate drug and device development to bring treatments to patients sooner
Medidata, a Dassault Systèmes company and leading provider...
Multi-year collaboration will enable development of complex, cutting-edge cell therapies and armoring technologies for solid tumor targets
Generate:Biomedicines and Roswell Park Comprehensive Cancer Center announced...
TSO 500 ctDNA Version 2 delivers faster turnaround time, greater analytical sensitivity, more streamlined workflow, further enabling precision medicine.
Illumina Inc., a global leader in...
Flagship Pioneering launched Pioneering Intelligence, an initiative of Flagship Pioneering harnessing artificial intelligence (AI) to accelerate innovation in the life sciences and beyond. Flagship...
23andMe Holding Co. announced a new, non-exclusive data license with GSK plc which extends their collaboration and enables GSK to conduct drug target discovery...
United Therapeutics Corporation and Miromatrix Medical Inc. announced a definitive agreement for United Therapeutics to acquire Miromatrix.
Miromatrix is a life sciences company focused on...
Can-Fite signed an agreement with Collaborations Pharmaceuticals, a leading expert in Artificial Intelligence and Machine Learning
Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline...
Pramana, Inc., an AI-enabled health tech company modernizing the pathology sector, and Techcyte, a leading developer of AI-based image analysis solutions for the diagnostics industry,...